Increasing Selectivity of CC Chemokine Receptor 8 Antagonists by Engineering Nondesolvation Related Interactions with the Intended and Off-Target Binding Sites
- 17 July 2009
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (23) , 7706-7723
- https://doi.org/10.1021/jm900713y
Abstract
The metabolic stability and selectivity of a series of CCR8 antagonists against binding to the hERG ion channel and cytochrome Cyp2D6 are studied by principal component analysis. It is demonstrated that an efficient way of increasing metabolic stability and selectivity of this series is to decrease compound lipophilicity by engineering nondesolvation related attractive interactions with CCR8, as rationalized by three-dimensional receptor models. Although such polar interactions led to increased compound selectivity, such a strategy could also jeopardize the DMPK profile of compounds. However, once increased potency is found, the lipophilicity can be readjusted by engineering hydrophobic substituents that fit to CCR8 but do not fit to hERG. Several such lipophilic fragments are identified by two-dimensional fragment-based QSAR analysis. Electrophysiological measurements and site-directed mutagenesis studies indicated that the repulsive interactions of these fragments with hERG are caused by steric hindrances with residue F656.Keywords
This publication has 86 references indexed in Scilit:
- Chemokine receptor antagonists: part 2Expert Opinion on Therapeutic Patents, 2009
- Chemokine receptor antagonists: Part 1Expert Opinion on Therapeutic Patents, 2009
- The 2.6 Angstrom Crystal Structure of a Human A2AAdenosine Receptor Bound to an AntagonistScience, 2008
- Structure of a β1-adrenergic G-protein-coupled receptorNature, 2008
- Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity RelationshipsJournal of Medicinal Chemistry, 2008
- High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled ReceptorScience, 2007
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Free energies of binding of R- and S-propranolol to wild-type and F483A mutant cytochrome P450 2D6 from molecular dynamics simulationsEuropean Biophysics Journal, 2007
- Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental ValidationJournal of Biological Chemistry, 2006
- Baseline Lipophilicity Relationships in Human Cytochromes P450 Associated with Drug MetabolismDrug Metabolism Reviews, 2003